COMPANIES COVERED
Eli LillyDownload FREE Report Sample
Download Free sampleAlzheimer's disease (AD), also referred to simply asAlzheimer's, is a chronic neurodegenerative diseasethat usually starts slowly and worsens over time. It is the cause of 60?70% of cases of dementia. The most common early symptom is difficulty in remembering recent events (short-term memory loss).
Alzheimers Disease Diagnostic Market contains market size and forecasts of Alzheimer's Disease Diagnostic in Global, including the following market information:
Global Alzheimer's Disease Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Alzheimer's Disease Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Genetic Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Alzheimer's Disease Diagnostic include Eli Lilly, TauRx, Alector, Accera, Treventis, Neuro-Bio and Cognition Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Alzheimer's Disease Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alzheimer's Disease Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Alzheimer's Disease Diagnostic Market Segment Percentages, by Type, 2021 (%)
Genetic Testing
Neurological Exam
Mini-Mental State Exam(MMSE)
Brain Imaging
Other
Global Alzheimer's Disease Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Alzheimer's Disease Diagnostic Market Segment Percentages, by Application, 2021 (%)
Clinics
Hospitals
Diagnostic Centers
Other
Global Alzheimer's Disease Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Alzheimer's Disease Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alzheimer's Disease Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Alzheimer's Disease Diagnostic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
TauRx
Alector
Accera
Treventis
Neuro-Bio
Cognition Therapeutics
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
